LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that President and CEO Safi Bahcall, Ph.D., will participate in a panel discussion titled New Targets in Cancer Therapy at the RBC Capital Markets Healthcare Conference on Tuesday, March 2 at 8:00 am (ET) at The New York Palace Hotel.
